IDEXX LABORATORIES INC /DE Income Taxes Receivable, Noncurrent
IDEXX LABORATORIES INC /DE (IDXX) had Income Taxes Receivable, Noncurrent of $1.55 million as of 2023-06-30, per its 10-Q filed 2023-08-01.
Discontinued › Notes › Receivables › and Others
us-gaap:IncomeTaxesReceivableNoncurrent · last filed 2023-08-01
- 2023-06-30: Income Taxes Receivable, Noncurrent $1.55M.
- 2023-03-31: Income Taxes Receivable, Noncurrent $1.55M.
- 2022-12-31: Income Taxes Receivable, Noncurrent $717.00K.
- 2022-09-30: Income Taxes Receivable, Noncurrent $539.00K.
| Period end | Income Taxes Receivable, Noncurrent |
|---|---|
| 2023-06-30 | $1.55M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $1.55M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $717.00K 10-Q · filed 2023-08-01 |
| 2022-09-30 | $539.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | $361.00K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $2.36M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.81M 10-K · filed 2023-02-16 |
| 2021-09-30 | $2.45M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $2.45M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $6.33M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $6.33M 10-K · filed 2022-02-16 |
| 2020-09-30 | $6.33M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $11.54M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $14.96M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $14.96M 10-K · filed 2021-02-12 |
| 2019-09-30 | $14.98M 10-Q · filed 2019-10-31 |
| 2018-12-31 | $19.22M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |